Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Cisplatin and Serum Albumin, Human

Research Papers that Mention the Interaction

Our findings show that HSA CDDP has the potential to be a novel therapeutic agent for SPARC-expressing tumors, enhancing the tumor targeting effect by HSA and reducing the nephrotoxicity of CDDP.
International journal of molecular sciences  •  2020  |  View Paper
Type I agents include cis-diamminedichloroplatinum (II), 4'-(9-acridinylamino)methanesulphon-m-anisidide, neocarzinostatin, nitrogen mustard, adriamycin, daunorubicin and mitomycin C--drugs whose biological activities are reduced in the presence of HA.
British Journal of Cancer  •  1980  |  View Paper
We noted that cisplatin incubation with HSA resulted in the formation of higher order HSA n‐mers, depending on the amount of cisplatin added.
Electrophoresis  •  2019  |  View Paper
In RNAi A549 cells, however, eHSA no longer weakened but enhanced the anticancer effect of DDP , while no longer altered the effect of VP-16.
Front. Pharmacol.  •  2016  |  View Paper